Titlebook: Hereditary Tyrosinemia; Pathogenesis, Screen Robert M. Tanguay Book 2017 The Editor(s) (if applicable) and The Author(s), under exclusive l

ALLY

書目名稱Hereditary Tyrosinemia影響因子(影響力)




書目名稱Hereditary Tyrosinemia影響因子(影響力)學(xué)科排名




書目名稱Hereditary Tyrosinemia網(wǎng)絡(luò)公開度




書目名稱Hereditary Tyrosinemia網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Hereditary Tyrosinemia被引頻次




書目名稱Hereditary Tyrosinemia被引頻次學(xué)科排名




書目名稱Hereditary Tyrosinemia年度引用




書目名稱Hereditary Tyrosinemia年度引用學(xué)科排名




書目名稱Hereditary Tyrosinemia讀者反饋




書目名稱Hereditary Tyrosinemia讀者反饋學(xué)科排名

CLIFF

BOAST

Liver Transplantation for Hereditary Tyrosinaemia Type 1 in the United Kingdom function appeared better, and hypertension less common in those treated in the Nitisinone era..Outcome was poorer for those four children with established malignancy; one was unfit for transplantation and another developed a pulmonary metastasis, which was successfully resected.

anchor

Liver Cancer in Tyrosinemia Type 1rease of the tumor marker α-fetoprotein is seen or if the α-fetoprotein concentrations remain just above the normal range. A rise of α-fetoprotein in these HT1 patients is more or less pathognomonic for liver cancer. Although hepatoblastoma development occurs in HT1 patients, most HT1 patients devel

針葉樹

Neurological and Neuropsychological Problems in Tyrosinemia Type I PatientsC treatment is started early and given continuously, all clinical problems seem to be solved. However, recent research findings indicate that HTI patients have a non-optimal neurocognitive outcome, showing (among others) a lower IQ and impaired executive functioning and social cognition. Unfortunate

deface

小樣他閑聊

Tyrosinemia Type I in Japan: A Report of Five Caseswherein residual activity was considerably present. When combined therapy with a low phenylalanine and tyrosine diet and NTBC administration is started after early diagnosis, patients can survive without liver transplantation. Development of liver cancer is not found in the cases in Japan, but perfo

轉(zhuǎn)折點(diǎn)

Newborn Screening for Hereditary Tyrosinemia Type I in Québec: Updatequantitative (Q) succinylacetone (SA) testing (red blood cells δ-aminolevulinate dehydratase inhibition), with immunoreactive FAH as the confirmatory test. This approach allowed to identify 118 of 123 affected newborns. In 1998, owing to earlier hospital discharge and increased rate of breastfeeding

少量

長處